BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27122107)

  • 1. Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals.
    Barco S; Heuschen CB; Salman B; Brekelmans MP; Serlie MJ; Middeldorp S; Coppens M
    J Thromb Haemost; 2016 Jul; 14(7):1364-73. PubMed ID: 27122107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Catheter occlusion and venous thrombosis prevention and incidence in adult home parenteral nutrition (HPN) programme patients].
    Puiggròs C; Cuerda C; Virgili N; Chicharro ML; Martínez C; Garde C; de Luis D;
    Nutr Hosp; 2012; 27(1):256-61. PubMed ID: 22566330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic anticoagulation in children receiving home parenteral nutrition.
    Nagelkerke SCJ; Schoenmaker MHA; Tabbers MM; Benninga MA; van Ommen CH; Gouw SC
    JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1036-1044. PubMed ID: 34719795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulants for the prevention and treatment of catheter-related thrombosis in adults and children on parenteral nutrition: a systematic review and critical appraisal.
    Barco S; Atema JJ; Coppens M; Serlie MJ; Middeldorp S
    Blood Transfus; 2017 Jul; 15(4):369-377. PubMed ID: 27483479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and management of complications of venous access in home parenteral nutrition (HPN): A 19 year longitudinal cohort series.
    Leiberman D; Stevenson RP; Banu FW; Gerasimidis K; McKee RF
    Clin Nutr ESPEN; 2020 Jun; 37():34-43. PubMed ID: 32359753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for people with cancer and central venous catheters.
    Kahale LA; Tsolakian IG; Hakoum MB; Matar CF; Barba M; Yosuico VE; Terrenato I; Sperati F; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006468. PubMed ID: 29856471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of catheter-related central vein thrombosis in home parenteral nutrition patients with benign disease using serial venous Doppler ultrasound.
    Cuerda C; Joly F; Corcos O; Concejo J; Puiggrós C; Gil C; Pironi L;
    Clin Nutr; 2016 Feb; 35(1):153-157. PubMed ID: 25660318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior vena cava syndrome in chronic intestinal failure patients: When the going gets tough.
    Gillis VELM; Korzilius JW; Wouters Y; Jenniskens SFM; Wanten GJA
    Clin Nutr; 2024 Jan; 43(1):197-202. PubMed ID: 38070211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism.
    White RH; Zhou H; Kim J; Romano PS
    Arch Intern Med; 2000 Jul; 160(13):2033-41. PubMed ID: 10888977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.
    Mismetti P; Laporte S; Pellerin O; Ennezat PV; Couturaud F; Elias A; Falvo N; Meneveau N; Quere I; Roy PM; Sanchez O; Schmidt J; Seinturier C; Sevestre MA; Beregi JP; Tardy B; Lacroix P; Presles E; Leizorovicz A; Decousus H; Barral FG; Meyer G;
    JAMA; 2015 Apr; 313(16):1627-35. PubMed ID: 25919526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis.
    Franco L; Giustozzi M; Agnelli G; Becattini C
    J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.
    Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F
    J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis.
    van Rein N; Biedermann JS; van der Meer FJM; Cannegieter SC; Wiersma N; Vermaas HW; Reitsma PH; Kruip MJHA; Lijfering WM
    J Thromb Haemost; 2017 Jul; 15(7):1386-1391. PubMed ID: 28440008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?
    Ihnat DM; Mills JL; Hughes JD; Gentile AT; Berman SS; Westerband A
    J Vasc Surg; 1998 Nov; 28(5):800-7. PubMed ID: 9808846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial.
    Barginear MF; Gralla RJ; Bradley TP; Ali SS; Shapira I; Greben C; Nier-Shoulson N; Akerman M; Lesser M; Budman DR
    Support Care Cancer; 2012 Nov; 20(11):2865-72. PubMed ID: 22421738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.